Brief Title
Study Evaluating Approach to Treatment of Haemophilia A and B in Spain
Official Title
Actual Approach to Treatment of Haemophilia A and B in Spain
Brief Summary
Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain.
Detailed Description
Analyze the clinical and therapeutic approach to treatment of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis. Assess haemophilia A or B patient profile, study different kinds of hanitual clinical treatment of haemophilia A and B patients, and estimate the kind of treatment and dosage units used per year in patients under habitual clinical practice conditions.
Study Type
Observational
Primary Outcome
Analyze the clinical and therapeutic approach to treament of haemophilia A and B in habitual clinical practice conditions in Spain during the first 3 years since diagnosis.
Secondary Outcome
Assess haemophilia A or B patient profile, study different kinds of habitual clinical treatment of haemophilia A and B patients, and estimate the dosage units used per year in patients under habitual clinical practice conditions.
Condition
Hemophilia A
Study Arms / Comparison Groups
1
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
52
Start Date
June 2007
Completion Date
December 2007
Primary Completion Date
December 2007
Eligibility Criteria
Inclusion Criteria: - Haemophilia A or B patients of any age - Written informed consent
Gender
All
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Medical Monitor, ,
Administrative Informations
NCT ID
NCT00581438
Organization ID
3082A-102378
Study Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Study Sponsor
Medical Monitor, Study Director, Wyeth is now a wholly owned subsidiary of Pfizer
Verification Date
December 2007